{
    "2018-02-20": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Novartis Plans to Launch RTH258 in 2019 to Treat nAMD",
                "features": {
                    "keywords": [
                        "Novartis",
                        "RTH258",
                        "nAMD",
                        "launch"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Wedbush: Restorbio's Therapy For Aging-Related Diseases Has Best-In-Class Potential",
                "features": {
                    "keywords": [
                        "Restorbio",
                        "therapy",
                        "aging-related",
                        "best-in-class"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Incyte (INCY) Q4 2017 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Q4",
                        "earnings",
                        "conference call"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Novartis Seeks to Acquire Advanced Accelerator Applications",
                "features": {
                    "keywords": [
                        "Novartis",
                        "acquire",
                        "Advanced Accelerator Applications"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Novartis Psoriasis Drug Cosentyx Positive in SCALP Study",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cosentyx",
                        "psoriasis",
                        "SCALP study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "GlaxoSmithKline’s Vaccines Business in 4Q17",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "vaccines",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Promacta and Jakavi May Boost Novartis’s Oncology Segment Revenues",
                "features": {
                    "keywords": [
                        "Promacta",
                        "Jakavi",
                        "Novartis",
                        "oncology",
                        "revenues"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Today’s Research Reports on Trending Tickers: UnitedHealth Group and Novartis",
                "features": {
                    "keywords": [
                        "UnitedHealth Group",
                        "Novartis",
                        "research reports"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "GlaxoSmithKline’s Global Pharmaceuticals Business in 4Q17",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "global",
                        "pharmaceuticals",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Kisqali: Therapy for Advanced Breast Cancer in Premenopausal Women",
                "features": {
                    "keywords": [
                        "Kisqali",
                        "breast cancer",
                        "premenopausal women"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Swiss Stock Market Climbed On Strength Of Financials",
                "features": {
                    "keywords": [
                        "Swiss stock market",
                        "climbed",
                        "financials"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}